Nalaganje...
Metyrapone in treatment-resistant depression
Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736936/ https://ncbi.nlm.nih.gov/pubmed/23983967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125312436597 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|